Healthline: What we know about Eli Lilly's experimental weight-loss drug – University of Cincinnati

According to drugmaker Eli Lilly, participants in a clinical trial lost over 50 pounds on average when they were treated with the highest dose of a new hunger suppressant.
The drug, called tirzepatide, is making headlines, but has not yet been approved or authorized by the Food and Drug Administration. Additionally, the initial research has been made public by the drug maker Eli Lilly and has not yet been published in a peer-reviewed medical journal.
In a story on the drug published by Healthline, one of the experts quoted is Shailendra Patel, MD, PhD, Division of Endocrinology, Diabetes and Metabolism in the Department of Internal Medicine at the UC College of Medicine.
Shailendra Patel, MD, PhD, Division of Endocrinology, Diabetes and Metabolism at the UC College of Medicine/Photo/Colleen Kelley/UC Creative + Brand
Patel told Healthline that approaches to weight loss have typically involved dieting but that diets often result only in short term weight loss because they are extremely difficult to stick with for an indefinite period of time.
“The reason that all these diets fail is that human beings cannot stick with any one of these diet plans forever,” he said.
Patel points out that due to the complexity of obesity relying on a single solution, whether a diet or a pill, is likely not going to work long term.
“We have yet another weight loss drug to help patients," said Patel. “But drugs by themselves, just like crash diets by themselves, you can see weight loss – but you won’t be successful.”
He said if people with obesity want to lose weight it may require multiple interventions some of which may include medical interventions.
Patel pointed out that even bariatric surgery, which involves shrinking or bypassing the stomach through surgery, requires patients to change their long-term approach to diet and exercise for the best results.
See the entire story here
Lead photo/Darron Cummings/AP
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city’s direction. Next Lives Here.

June 7, 2022
Jennifer Bard, PhD, professor in the University of Cincinnati College of Law, spoke with Columbus Dispatch about a story on the legality of THC compounds sold in Ohio stores. THC, or tetrahydrocannabinol, is the chemical responsible for most of marijuana's psychological effects.

June 7, 2022
A chemical engineering professor at the University of Cincinnati will work with a South Korean pharmaceutical company to develop new cancer treatments using the technology found in some COVID-19 vaccines UC College of Engineering and Applied Science professor Joo-Youp Lee will work with Yuhan Corp. and Ewha Womans University in South Korea to improve the delivery of treatments that use messenger RNA and lipid nanoparticles. This technology also is being used to treat infectious diseases and genetic disorders.

June 7, 2022
In an attempt to slow inflation, the Federal Reserve will raise interest rates until consumer demand decreases to a more suitable level, a University of Cincinnati economics professor said on 700WLW.

University of Cincinnati
2600 Clifton Ave.
Cincinnati, OH 45220
513-556-0000
UC Tools
About Us
University of Cincinnati | 2600 Clifton Ave. | Cincinnati, OH 45221 | ph: 513-556-6000
Alerts | Clery and HEOA Notice | Notice of Non-Discrimination | eAccessibility Concern | Privacy Statement | Free Speech | Copyright Information
© 2020 University of Cincinnati
University of Cincinnati
2600 Clifton Ave.
Cincinnati, OH 45220
513-556-0000
© 2020 University of Cincinnati

source

Leave a Reply

Your email address will not be published. Required fields are marked *

Prev
The Words We Lose: The Merits and Disadvantages of Reading Translated Literature | Arts – Harvard Crimson

The Words We Lose: The Merits and Disadvantages of Reading Translated Literature | Arts – Harvard Crimson

NewsMass

Next
Everything Heather Rae Young and Christina Haack Have Said About Their Relationship – Us Weekly

Everything Heather Rae Young and Christina Haack Have Said About Their Relationship – Us Weekly

Top 5Stories From one Mrs

You May Also Like